Table 1.
Clinical symptoms, laboratory findings, and computed tomography findings
| XGC (n = 6) | GB carcinoma (n = 16) | P value | |
| Age (mean ± SD, yr) | 64.3 ± 9.7 | 67.9 ± 12.0 | 0.5148 |
| Gender | 0.8558 | ||
| Male | 4 | 8 | |
| Female | 2 | 8 | |
| Abdominal pain | 0.4806 | ||
| Presence | 4 | 8 | |
| Absence | 2 | 8 | |
| Fever | 0.4726 | ||
| Yes | 1 | 1 | |
| No | 5 | 15 | |
| Jaundice | 0.6707 | ||
| Yes | 1 | 4 | |
| No | 5 | 12 | |
| Albumin (mean ± SD, mg/dL) | 3.8 ± 0.4 | 3.8 ± 0.3 | 0.8090 |
| Neutrophil/lymphocyte ratio (mean ± SD) | 2.1 ± 0.9 | 2.4 ± 1.0 | 0.6280 |
| CEA (mean ± SD) | 1.9 ± 0.6 | 3.1 ± 3.5 | 0.2205 |
| CA19-9 (mean ± SD) | 232.7 ± 488.5 | 354.0 ± 737.1 | 0.6806 |
| Cholecystolithiasis | 0.0116 | ||
| Yes | 5 | 4 | |
| No | 1 | 12 | |
| Diffuse gallbladder wall thickening (CT findings) | 0.1551 | ||
| Yes | 3 | 3 | |
| No | 3 | 13 | |
| Continuous mucosal line (CT findings) | 0.0616 | ||
| Yes | 3 | 2 | |
| No | 3 | 14 | |
| Intramural hypoattenuated nodule | 0.0024 | ||
| Yes | 3 | 1 | |
| No | 3 | 15 | |
| Bile duct dilatation | 0.9035 | ||
| Yes | 1 | 3 | |
| No | 5 | 13 | |
XGC: Xanthogranulomatous cholecystitis; GB: Gall bladder; CT: Computed tomography.